Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Oncology
Institutions: LungenClinic Grosshansdorf, Assistance Publique Hôpitaux de Marseille, Christian Medical College, Vellore, Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Bristol-Myers Squibb (United States), Yale Cancer Center, Smilow Cancer Hospital
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2155599713